The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,440.00
Bid: 1,440.00
Ask: 1,443.00
Change: 2.00 (0.14%)
Spread: 3.00 (0.208%)
Open: 1,432.00
High: 1,444.00
Low: 1,427.00
Prev. Close: 1,438.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE: Pay comes under spotlight at BAE, Indivior and Rio Tinto AGMs

Thu, 06th May 2021 17:50

(Alliance News) - Shareholders voiced their discontent with executive pay on Thursday, with BAE Systems PLC, Indivior PLC and Rio Tinto PLC all seeing varying sizes of AGM rebellion.

At BAE's annual general meeting, resolution two, which concerned the directors' remuneration report, was passed by 76.59% of votes cast.

The company noted the vote outcome, and said it was "very appreciative of the support the resolution received in a challenging period"

"The importance of retaining the services of a first class chief executive on competitive terms by a one-off remuneration adjustment was taken in the interests of all stakeholders, and was explained in detail in our annual report and through personal engagement with shareholders accounting for nearly 70% of the company's share capital. Our depth of engagement was positively received as was the exceptional level of transparency in both our dialogue and the annual report," said BAE.

It "may not be possible to please all our stakeholders all of the time", but the defence firm said it will continue to engage with shareholders.

Indivior also saw a sizeable minority vote against approval of the directors' remuneration report, with 38.3% of votes cast at the AGM against and just under 62% in favour. The pharmaceutical firm was "disappointed" by the outcome of the vote.

"In the run-up to the AGM we engaged with a number of shareholders to understand their concerns, which we understand related to the termination arrangements for the former chief executive officer, Shaun Thaxter. The remuneration committee determined, based on Thaxter's leadership that produced years of positive operational performance, and the absence of any findings of personal wrongdoing or malfeasance, to allow Thaxter to retain his outstanding LTIP awards," said Indivior.

Indivior also noted that resolution 14, which concerned the re-election of Daniel Phelan as a director, was passed with 78.5% shareholder support. The company will continue to engage with "our largest shareholders on governance and remuneration matters", it said.

Despite some minority rebellions, all resolutions at both BAE and Indivior's AGMs - including those on remuneration - were passed.

However, miner Rio Tinto earlier in the day saw shareholders actually vote against advisory resolutions on executive remuneration, admitting that pay is a contentious issue after the company destroyed the Juukan Gorge Aboriginal heritage site in Australia.

Holders of 61% of shares voted against the two resolutions, on the directors' remuneration report and the implementation report, excluding abstentions and withheld votes.

"The board acknowledges that the executive pay outcomes in relation to the tragic events at Juukan Gorge are sensitive and contentious issues," the company said. It added that it will engage further with shareholders, before outlining any additional measures in response to the feedback at next year's annual general meeting.

Outcry and regulatory scrutiny followed the company after it blew up a 46,000-year-old Aboriginal heritage site to expand the Pilbara iron ore mine in Western Australia.

In May of last year, Rio Tinto had blasted rock shelters in the Juukan Gorge in Western Australia's remote Pilbara region, destroying one of the earliest known sites occupied by Australia's indigenous people, in order to expand its iron ore mine.

Shares in Indivior closed up 1.7% at 155.86 pence in London on Thursday, while BAE shares rose 0.9% to 504.41p. Rio Tinto shares gained 1.1% to 6,477.00p.

By Ivan Edwards; ivanedwards@alliancenews.com; Updated by Lucy Heming; lucyheming@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
20 Feb 2023 09:15

LONDON BROKER RATINGS: Berenberg lowers Spectris; RBC cuts Direct Line

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
16 Feb 2023 16:55

LONDON MARKET CLOSE: Records for FTSE and CAC but US PPI hits New York

(Alliance News) - Blue-chip benchmarks in London and Paris hit record highs on Thursday, with the FTSE 100 managing to cling to its daily gain, despite some weakness following US producer price data.

Read more
16 Feb 2023 12:19

CORRECT: LONDON MARKET MIDDAY: FTSE 100 stays above 8,000

(Correcting the GBPUSD quote).

Read more
16 Feb 2023 12:07

LONDON MARKET MIDDAY: FTSE 100 stays above 8,000 as Centrica jumps

(Alliance News) - Stock prices in London were higher at midday on Thursday, with London's flagship index still trading above the 8,000 mark on the back of strong performances from Centrica and Relx.

Read more
16 Feb 2023 10:10

CORRECT: Indivior shares down on swing to annual loss

(Correcting litigation provision is against 2022 results.)

Read more
16 Feb 2023 10:09

TOP NEWS: Indivior shares down on swing to annual loss

(Alliance News) - Indivior PLC on Thursday reported a swing to a full-year loss due to a provision for litigation, despite net revenue jumping by 14% due to growth in its Sublocade injection.

Read more
16 Feb 2023 08:49

LONDON MARKET OPEN: FTSE 100 tops 8,000; Centrica is star performer

(Alliance News) - Stock prices in London opened higher on Thursday, with London's blue-chip index pushing past the 8,000 mark once again, a day after it first broke the barrier.

Read more
16 Feb 2023 07:55

LONDON BRIEFING: Centrica, Indivior swing to loss; StanChart bullish

(Alliance News) - Stocks in London were set to open higher on Thursday, with the FTSE 100 called to push past the 8,000 mark again at the open.

Read more
16 Feb 2023 07:54

Indivior shares tumble as group sets aside $290m for US litigation

(Sharecast News) - Shares in pharmaceuticals business Indivior tumbled early on Thursday after the group revealed it had put aside $290.0m for ongoing litigation in the States.

Read more
9 Feb 2023 15:47

UK earnings, trading statements calendar - next 7 days

Friday 10 February 
Ince Group PLCFull Year Results (TBC)
Lancashire Holdings LtdFull Year Results
S&U PLCTrading Statement
Victrex PLCTrading Statement
Monday 13 February 
no events scheduled 
Tuesday 14 February 
Carr's Group PLCFull Year Results
Coca-Cola HBC AGFull Year Results
Plus500 LtdFull Year Results
Tui AGQ1 Results
UP Global Sourcing Holdings PLCTrading Statement
Wednesday 15 February 
Barclays PLCFull Year Results
Brunner Investment Trust PLCFull Year Results
Dunelm Group PLCHalf Year Results
Equipmake Holdings PLCHalf Year Results
Glencore PLCFull Year Results
Hargreaves Lansdown PLCHalf Year Results
Pan African Resources PLCHalf Year Results
Thursday 16 February 
Centrica PLCFull Year Results
Coca-Cola Europacific Partners PLCFull Year Results
Indivior PLCFull Year Results
MJ Gleeson PLCHalf Year Results
Moneysupermarket.com Group PLCFull Year Results
Relx PLCFull Year Results
Riverstone Credit Opportunities Income PLCFull Year Results
South32 LtdHalf Year Results
Standard Chartered PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
6 Feb 2023 16:32

Indivior announces expiry of waiting period for Opiant purchase

(Alliance News) - Indivior PLC has announced on Monday the expiration of the waiting period relating to its USD145 million purchase of Opiant Pharmaceuticals Inc.

Read more
7 Dec 2022 17:25

LONDON MARKET CLOSE: Pharma stocks fail to lift FTSE 100 in the green

(Alliance News) - Stocks in London closed in the red on Wednesday, despite a strong performance from pharmaceutical stocks, as investors digested a raft of economic data from both China and Europe.

Read more
7 Dec 2022 11:44

Indivior targets Nasdaq listing for spring 2023 as hails Sublocade

(Alliance News) - Indivior PLC on Wednesday said it aims to list on the Nasdaq in spring 2023 as it expects its injection Sublocade to reach peak annual net revenue of over USD1.5 billion.

Read more
7 Dec 2022 08:59

Indivior raises guidance for peak net revenue potential of Sublocade asset

(Sharecast News) - Pharmaceuticals business Indivior upgraded guidance for the peak annual net revenue potential of its Sublocade asset on Wednesday ahead of its Capital Markets Day event in New York City.

Read more
14 Nov 2022 11:16

Indivior buys Opiant creating "comprehensive" treatment platform

(Alliance News) - Indivior PLC on Monday announced the acquisition of Opiant Pharmaceuticals Inc for around USD145 million.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.